指南与共识卫生政策与健康促进传染病防控与疫情报告

全球儿童腹泻相关死亡估计与模型:数据集与研究选择建议

Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection.
指南 / 共识 · Vaccine · 2021-06-13

该指南由WHO工作组指导,比较IHME与MCEE模型所用ETEC和志贺菌死亡估计研究,用改良NOS评估质量。两模型纳入研究不同但多数高质量,SEAR、AFR和WPR国家研究偏多。提出未来肠道疾病死亡估计的研究选择建议。

要点

  • IHME与MCEE模型纳入的ETEC和志贺菌研究集不同,影响死亡估计。
  • 多数纳入研究质量高,NOS评分分布两组相似。
  • SEAR、AFR和WPR国家研究相对其他WHO区域偏多。

核心结论

  • IHME与MCEE在ETEC和志贺菌死亡估计中纳入研究标准存在关键差异,影响数据集与估计结果。

研究设计与样本

  • 指南类文件,由WHO工作组指导,比较IHME与MCEE模型用于2016年ETEC和志贺菌死亡估计的研究,并用改良NOS评估研究质量。

主要发现

  • 两模型组使用的ETEC和志贺菌研究集不同,但多数研究质量高,NOS评分分布相似。
  • SEAR、AFR和WPR的部分国家研究相对其他WHO区域偏多。

关键数值与推荐

  • 采用改良纽卡斯尔-渥太华量表(NOS)评估纳入研究质量。
  • 基于研究纳入与排除标准差异,提出未来肠道疾病死亡估计的研究选择建议。

临床怎么用

  • 在解读儿童腹泻死亡估计时,应关注模型所用研究纳入标准与数据集差异。
  • 未来计算肠道疾病死亡负担时,可参考本指南的研究选择建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple factors contribute to variation in disease burden, including the type and quality of data, and inherent properties of the models used. Understanding how these factors affect mortality estimates is crucial, especially in the context of public health decision making. We examine how the quality of the studies selected to provide mortality data, influence estimates of burden and provide recommendations about the inclusion of studies and datasets to calculate mortality estimates. METHODS: To determine how mortality estimates are affected by the data used to generate model outputs, we compared the studies used by The Institute of Health Metrics and Evaluation (IHME) and Maternal and Child Epidemiology Estimation (MCEE) modelling groups to generate enterotoxigenic Escherichia coli (ETEC) and Shigella-associated mortality estimates for 2016. Guided by an expert WHO Working Group, we applied a modified Newcastle-Ottawa Scale (NOS) to evaluate the quality of studies used by both modelling groups. RESULTS: IHME and MCEE used different sets of ETEC and Shigella studies in their models and the majority of studies were high quality. The distribution of the NOS scores was similar between the two modelling groups. We observed an overrepresentation of studies from some countries in SEAR, AFR and WPR compared to other WHO regions. CONCLUSION: We identified key differences in study inclusion and exclusion criteria used by IHME and MCEE and discuss their impact on datasets used to generate diarrhoea-associated mortality estimates. Based on these observations, we provide a set of recommendations for future estimates of mortality associated with enteric diseases.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Butkeviciute E, Prudden HJ, Jit M, et al. Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection. Vaccine. 2021. PMID: 34134905. doi:10.1016/j.vaccine.2021.05.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。